Literature DB >> 31996326

Motoric cognitive risk syndrome: Integration of two early harbingers of dementia in older adults.

Richard D Semba1, Qu Tian2, Michelle C Carlson3, Qian-Li Xue4, Luigi Ferrucci2.   

Abstract

Dementia is characterized by a long preclinical phase that may last years to decades before the onset of mild cognitive impairment. Slow gait speed and subjective memory complaint commonly co-occur during this preclinical phase, and each is a strong independent predictor of cognitive decline and dementia. Motoric cognitive risk (MCR) syndrome is a pre-dementia syndrome that combines these two early harbingers of dementia. The risk of cognitive decline or dementia is stronger for MCR than for either slow gait speed or subjective memory complaint alone. Slow gait speed and subjective memory complaint have several common risk factors: cardiovascular disease, diabetes mellitus, abnormal cortisol profiles, low vitamin D levels, brain atrophy with decreased hippocampal volume, and increased deposition of beta-amyloid in the brain. The underlying pathogenesis of MCR remains poorly understood. Metabolomics and proteomics have great potential to provide new insights into biological pathways involved in MCR during the long preclinical phase preceding dementia.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Cognitive decline; Dementia; Gait; Memory; Skeletal muscle

Mesh:

Year:  2020        PMID: 31996326      PMCID: PMC7697173          DOI: 10.1016/j.arr.2020.101022

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  280 in total

1.  Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring Study.

Authors:  Joanne B Krasnoff; Shehzad Basaria; Michael J Pencina; Guneet K Jasuja; Ramachandran S Vasan; Jagadish Ulloor; Anqi Zhang; Andrea Coviello; Margaret Kelly-Hayes; Ralph B D'Agostino; Philip A Wolf; Shalender Bhasin; Joanne M Murabito
Journal:  J Clin Endocrinol Metab       Date:  2010-04-09       Impact factor: 5.958

2.  Plasma phospholipids identify antecedent memory impairment in older adults.

Authors:  Mark Mapstone; Amrita K Cheema; Massimo S Fiandaca; Xiaogang Zhong; Timothy R Mhyre; Linda H MacArthur; William J Hall; Susan G Fisher; Derick R Peterson; James M Haley; Michael D Nazar; Steven A Rich; Dan J Berlau; Carrie B Peltz; Ming T Tan; Claudia H Kawas; Howard J Federoff
Journal:  Nat Med       Date:  2014-03-09       Impact factor: 53.440

3.  Subjective Cognitive Complaints, Personality and Brain Amyloid-beta in Cognitively Normal Older Adults.

Authors:  Beth E Snitz; Lisa A Weissfeld; Ann D Cohen; Oscar L Lopez; Robert D Nebes; Howard J Aizenstein; Eric McDade; Julie C Price; Chester A Mathis; William E Klunk
Journal:  Am J Geriatr Psychiatry       Date:  2015-02-11       Impact factor: 4.105

4.  Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women.

Authors:  Anne R Cappola; Qian-Li Xue; Luigi Ferrucci; Jack M Guralnik; Stefano Volpato; Linda P Fried
Journal:  J Clin Endocrinol Metab       Date:  2003-05       Impact factor: 5.958

5.  Glucose metabolism, gray matter structure, and memory decline in subjective memory impairment.

Authors:  Lukas Scheef; Annika Spottke; Moritz Daerr; Alexius Joe; Nadine Striepens; Heike Kölsch; Julius Popp; Marcel Daamen; Dominik Gorris; Michael T Heneka; Henning Boecker; Hans J Biersack; Wolfgang Maier; Hans H Schild; Michael Wagner; Frank Jessen
Journal:  Neurology       Date:  2012-08-22       Impact factor: 9.910

6.  Increased follistatin associated with decreased gait speed among old adults.

Authors:  Fang-Yih Liaw; Tung-Wei Kao; Wen-Hui Fang; Der-Sheng Han; Yu-Chiao Chi; Wei-Shiung Yang
Journal:  Eur J Clin Invest       Date:  2016-02-20       Impact factor: 4.686

7.  Memory complaints and memory impairment in older individuals.

Authors:  C Jonker; L J Launer; C Hooijer; J Lindeboom
Journal:  J Am Geriatr Soc       Date:  1996-01       Impact factor: 5.562

8.  Longitudinal Associations Between Walking Speed and Amount of Self-reported Time Spent Walking Over a 9-Year Period in Older Women and Men.

Authors:  John R Best; Teresa Liu-Ambrose; Andrea L Metti; Andrea L Rosso; Suzanne Satterfield; Stephanie Studenski; Anne B Newman; Caterina Rosano
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-08-10       Impact factor: 6.053

9.  Lysophosphatidylcholine and amide as metabolites for detecting alzheimer disease using ultrahigh-performance liquid chromatography-quadrupole time-of-flight mass spectrometry-based metabonomics.

Authors:  Yu Cui; Xiuqin Liu; Maoqing Wang; Liyan Liu; Xiaohong Sun; Lan Ma; Wei Xie; Chao Wang; Sisi Tang; Decai Wang; Qunhong Wu
Journal:  J Neuropathol Exp Neurol       Date:  2014-10       Impact factor: 3.685

10.  Gait speed under varied challenges and cognitive decline in older persons: a prospective study.

Authors:  Nandini Deshpande; E Jeffrey Metter; Stefania Bandinelli; Jack Guralnik; Luigi Ferrucci
Journal:  Age Ageing       Date:  2009-06-23       Impact factor: 10.668

View more
  12 in total

1.  Association between gait features assessed by artificial intelligent system and cognitive function decline in patients with silent cerebrovascular disease: study protocol of a multicenter prospective cohort study (ACCURATE-2).

Authors:  Yan-Min Tang; Bei-Ni Fei; Xin Li; Jin Zhao; Wei Zhang; Guo-You Qin; Min Hu; Jing Ding; Xin Wang
Journal:  BMC Neurol       Date:  2022-06-30       Impact factor: 2.903

2.  Reward System Dysfunction and the Motoric-Cognitive Risk Syndrome in Older Persons.

Authors:  Fulvio Lauretani; Crescenzo Testa; Marco Salvi; Irene Zucchini; Beatrice Lorenzi; Sara Tagliaferri; Chiara Cattabiani; Marcello Maggio
Journal:  Biomedicines       Date:  2022-03-30

3.  The Association Between Subjective Age and Motoric Cognitive Risk Syndrome: Results From a Population-Based Cohort Study.

Authors:  Yannick Stephan; Angelina R Sutin; Brice Canada; Antonio Terracciano
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2021-11-15       Impact factor: 4.077

4.  Risk factors for the progression of motoric cognitive risk syndrome to dementia: Retrospective cohort analysis of two populations.

Authors:  Zeev Meiner; Emmeline Ayers; David A Bennett; Cuiling Wang; Joe Verghese
Journal:  Eur J Neurol       Date:  2021-04-14       Impact factor: 6.288

5.  Motoric Cognitive Risk Syndrome Using Three-Item Recall Test and Its Associations with Fall-Related Outcomes: The Korean Frailty and Aging Cohort Study.

Authors:  Hayoung Shim; Miji Kim; Chang Won Won
Journal:  Int J Environ Res Public Health       Date:  2020-05-12       Impact factor: 3.390

6.  Cerebellar-limbic neurocircuit is the novel biosignature of physio-cognitive decline syndrome.

Authors:  Li-Kuo Liu; Kun-Hsien Chou; Chih-Chin Heather Hsu; Li-Ning Peng; Wei-Ju Lee; Wei-Ta Chen; Ching-Po Lin; Chih-Ping Chung; Pei-Ning Wang; Liang-Kung Chen
Journal:  Aging (Albany NY)       Date:  2020-11-25       Impact factor: 5.682

Review 7.  Motoric Cognitive Risk Syndrome: Symptoms, Pathology, Diagnosis, and Recovery.

Authors:  Ke Xiang; Yin Liu; Li Sun
Journal:  Front Aging Neurosci       Date:  2022-02-02       Impact factor: 5.750

8.  Sarcopenia and motoric cognitive risk syndrome: a moderated mediation model.

Authors:  Ting Zhang; Yunyun Zhang; Ziyan Lv; Jie Xiang
Journal:  BMC Geriatr       Date:  2022-02-19       Impact factor: 3.921

9.  Motoric Cognitive Risk Syndrome, Subtypes and 8-Year All-Cause Mortality in Aging Phenotypes: The Salus in Apulia Study.

Authors:  Ilaria Bortone; Roberta Zupo; Fabio Castellana; Simona Aresta; Luisa Lampignano; Sabrina Sciarra; Chiara Griseta; Tommaso Antonio Stallone; Giancarlo Sborgia; Madia Lozupone; Francesco Panza; Gianvito Lagravinese; Petronilla Battista; Rodolfo Sardone
Journal:  Brain Sci       Date:  2022-06-29

10.  Purpose in Life and Motoric Cognitive Risk Syndrome: Replicable Evidence from Two National Samples.

Authors:  Angelina R Sutin; Martina Luchetti; Yannick Stephan; Antonio Terracciano
Journal:  J Am Geriatr Soc       Date:  2020-09-30       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.